Requires Medicaid coverage for ovulation enhancing drugs and related medical services for certain beneficiaries experiencing infertility.
Advances the coverage of ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility. The bill mandates that Medicaid provide coverage for expenses incurred in the provision of medically necessary ovulation enhancing drugs and the medical services related to prescribing and monitoring the use of such drugs for individuals aged 21 through 44 who are experiencing infertility, provided that there is federal financial participation available.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.